DNA Script takes in Series A

Paris-based DNA Script, a synthetic DNA manufacturer, has raised 11 million euros in Series A funding. The investors were Sofinnova Partners, Kurma Partners, Idinvest Partners, Illumina Ventures and Merck Ventures BV.

North AmericaUSBriefs